Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer Initiation
Epigenomes · 10.03.2026 · 10 (1) · 19
DOI: 10.3390/epigenomes10010019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epigenomes, online erschienen am 10.03.2026. Verfasst von Gareth Pollin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) arises predominantly from activating KRAS mutations, yet individual genetic variants differ markedly in signaling output and clinical impact. G12D, the most prevalent variant, strongly drives oncogenic programs, whereas G12R signals less efficiently through the AKT and ERK pathways and is associated with longer patient survival than G12D-driven PDAC.
Methods
To elucidate how these differences influence early cellular transformation, we expressed a panel of KRAS mutants in non-cancerous pancreatic ductal epithelial cells as a model of early PDAC initiation and profiled transcriptional and phospho-proteomic responses. We next examined whether epigenetic differences translate into mutation-specific changes in nuclear organization using quantitative imaging of G12D- and G12R-expressing nuclei at 24 and 48 h.
Results
Each variant established a unique regulatory program enriched for chromatin remodelers, histone modifiers, and nuclear structural factors, indicating that variant-specific KRAS signaling rapidly develops divergent epigenetic states. Integrated transcriptomic and phospho-proteomic analyses identified G12D and G12R as the most divergent variants. G12D induced pronounced nuclear remodeling, including increased nuclear size, irregular morphology, and reorganization of the nucleolus and spliceosome, consistent with extensive chromatin and transcriptional reprogramming. In contrast, G12R elicited a weaker response, with minimal or delayed structural changes.
Conclusions
Together, these findings demonstrate that KRAS mutational context in pancreatic ductal epithelial cells shapes early transcriptional reprogramming that actively remodels nuclear architecture and nuclear sub-compartments. This work establishes nuclear structural remodeling as a structural state of KRAS-driven epigenetic dysregulation during PDAC initiation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Division of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Centre de Recherche en Cancérologie de Marseille (CRCM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique…
- Department of Solid Organ Transplantation and Hepatobiliary Surgery, Bon Secours Mercy Health St. Vincent Medical Center, Toledo, OH 43608, USA.
- Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Data Science Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
ORCID-Profile: Gareth Pollin, Angela J Mathison, Thiago Milech De Assuncao, Michael T Zimmermann, Raul Urrutia, Gwen Lomberk
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIH
- Advancing a Healthier Wisconsin MCW Post-Doctoral Researcher Seed Grant
- Linda T and John A Mellowes Endowed Innovation and Discovery Fund
- Joel and Arlene Lee Endowed Chair
- Markus Family Funds for Discovery and Innovation Family Funds to the Mellowes Center
Zitieren
APA
Pollin, G., Mathison, A. J., Leverence, E. N., De Assuncao, T. M., Iovanna, J., Hong, J. C., Zimmermann, M. T., Urrutia, R., & Lomberk, G. (2026). Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer Initiation. Epigenomes, 10(1), 19. https://doi.org/10.3390/epigenomes10010019
Vancouver
Pollin G, Mathison AJ, Leverence EN, De Assuncao TM, Iovanna J, Hong JC, et al. Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer Initiation. Epigenomes. 2026;10(1):19. doi:10.3390/epigenomes10010019
BibTeX
@article{Pollin2026,
author = {Pollin, Gareth and Mathison, Angela J and Leverence, Elise N and De Assuncao, Thiago Milech and Iovanna, Juan and Hong, Johnny C and Zimmermann, Michael T and Urrutia, Raul and Lomberk, Gwen},
title = {Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer Initiation},
journal = {Epigenomes},
year = {2026},
volume = {10},
number = {1},
pages = {19},
doi = {10.3390/epigenomes10010019}
}
EUVIMED